Back to top
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Redhill Biopharma Ltd. (RDHL) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Redhill Biopharma Ltd. (RDHL) - free report >>
Image: Bigstock
Top Ranked Momentum Stocks to Buy for April 7th
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 7th:
RedHill Biopharma Ltd. (RDHL - Free Report) : This specialty biopharmaceutical company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 36.7% over the last 60 days.
Redhill Biopharma Ltd. Price and Consensus
Redhill Biopharma Ltd. price-consensus-chart | Redhill Biopharma Ltd. Quote
RedHill Biopharma’s shares gained 1.1% over the last one month above the S&P 500’s decrease of 10.4%. The company possesses a Momentum Score of A.
Redhill Biopharma Ltd. Price
Redhill Biopharma Ltd. price | Redhill Biopharma Ltd. Quote
Euronav NV (EURN - Free Report) : This company that engages in the transportation and storage of crude oil and petroleum products has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 43.6% over the last 60 days.
Euronav NV Price and Consensus
Euronav NV price-consensus-chart | Euronav NV Quote
Euronav’s shares gained 8.9% over the last one month. The company possesses a Momentum Score of A.
Euronav NV Price
Euronav NV price | Euronav NV Quote
Summit Therapeutics plc (SMMT - Free Report) : This biopharmaceutical company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.3% over the last 60 days.
Summit Therapeutics PLC Price and Consensus
Summit Therapeutics PLC price-consensus-chart | Summit Therapeutics PLC Quote
Summit Therapeutics’ shares gained 40% over the last one month. The company possesses a Momentum Score of B.
Summit Therapeutics PLC Price
Summit Therapeutics PLC price | Summit Therapeutics PLC Quote
LiveXLive Media, Inc. : This digital media company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 2.7% over the last 60 days.
LiveXLive Media, Inc. Price and Consensus
LiveXLive Media, Inc. price-consensus-chart | LiveXLive Media, Inc. Quote
LiveXLive Media’s shares gained 16.8% over the last one month. The company possesses a Momentum Score of B.
LiveXLive Media, Inc. Price
LiveXLive Media, Inc. price | LiveXLive Media, Inc. Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Today's Best Stocks from Zacks
Would you like to see the updated picks from our best market-beating strategies? From 2017 through 2019, while the S&P 500 gained and impressive +53.6%, five of our strategies returned +65.8%, +97.1%, +118.0%, +175.7% and even +186.7%.
This outperformance has not just been a recent phenomenon. From 2000 – 2019, while the S&P averaged +6.0% per year, our top strategies averaged up to +54.7% per year.
See their latest picks free >>